Comparison of a SARS-CoV-2 mRNA booster immunization containing additional antigens to a spike-based mRNA vaccine against Omicron BA.5 infection in hACE2 mice.
The emergence of SARS-CoV-2 variants presents challenges to vaccine effectiveness, underlining the necessity for next-generation vaccines with multiple antigens beyond the spike protein. Here, we investigated a multiantigenic booster containing spike and a chimeric construct composed of nucleoprotei...
        Saved in:
      
    
          | Main Authors: | Jacklyn R Hurst, Maedeh Naghibosadat, Patrick Budowski, Jun Liu, Philip Samaan, Frans Budiman, Alexandra Kurtesi, Fredo Qi, Haritha Menon, Rajesh Krishnan, Jumai Abioye, Anne-Claude Gingras, Mario Ostrowski, Natalia Martin Orozco, Robert A Kozak | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | Public Library of Science (PLoS)
    
        2024-01-01 | 
| Series: | PLoS ONE | 
| Online Access: | https://doi.org/10.1371/journal.pone.0314061 | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
Similar Items
- 
                
                    Safety and immunogenicity of an mRNA-1273 vaccine booster in adolescents        
                          
 by: Amparo L. Figueroa, et al.
 Published: (2025-12-01)
- 
                
                    BNT162b2 versus mRNA-1273 mRNA COVID-19 vaccines as the third booster for the patients with underlying cancer        
                          
 by: Amnuay Kleebayoon, et al.
 Published: (2023-12-01)
- 
                
                    Nuclear mRNA export        
                          
 by: Chen Suli, et al.
 Published: (2024-09-01)
- 
                
                    Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes        
                          
 by: Ramandip Grewal, et al.
 Published: (2023-03-01)
- 
                
                    mRNA vaccines as cancer therapies        
                          
 by: Shaoxiong Huang, et al.
 Published: (2024-12-01)
 
       